Anti-Aging Therapeutics Market to Reach $2.01 Billion by 2030 – Exclusive Report by Insight Analytics
Insight Analytics Pvt. Ltd. has announced the release of a market assessment report on “Global Anti-Aging Therapeutics Market – By Molecule Type (Biologics and Small Molecules), By Type of Aging (Cellular Senescence, Immunosenescence, Metabolic Senescence, etc.), By Mechanism of Action (Senolytics, Cellular Regeneration, mTOR Inhibitors/Modulators, AMP Kinase/AMP Activators, Mitochondrial Inhibitors/Modulators, etc.), Trends, Industry Competitive Analysis, Revenue, Forecast to 2030.”
Get a Free Sample Copy of the Report: https://www.insightaceanalytic.com/request-sample/1249
The growing global population and longer life expectancy have led to a surge in age-related diseases, creating major challenges for both individuals and healthcare systems. This has paved the way for a revolutionary field of medicine: anti-aging therapeutics. Valued at USD 518.86 million in 2021, the anti-aging therapeutics market is projected to reach a staggering USD 2,013.51 million by 2030, growing at a robust CAGR of 16.53% (Insight Analytics).
Anti-aging therapeutics aim to diagnose, treat and in some cases reverse the dysfunctions, illnesses and diseases associated with aging. This exciting medical frontier utilizes a variety of models, including cells, insects and animals, to develop anti-aging drugs prior to human testing. Companies that have successfully introduced longevity therapeutics are seeing great promise in this fast-growing market.
However, the road to effective anti-aging treatments is not without hurdles. The complex clinical trial process can pose challenges. Despite these obstacles, there are two main factors driving the market forward:
• Increasing demand for personalized, precise, preventative and participatory anti-aging solutions: As individuals become more proactive about their health, there is an increasing demand for preventative and personalized anti-aging therapies.
• Increasing elderly population: As the population ages, the demand for anti-aging treatments naturally increases.
Additionally, technological advancements and significant R&D investments in anti-aging products are driving the market forward. Companies are actively developing innovative anti-aging solutions to meet the growing consumer demand for technologically advanced treatments.
Geographically, North America is expected to continue to be a major player in the anti-aging therapeutics market, owing to increasing investments in pharmaceutical research and development, especially in senescent cell research and drug manufacturing. Moreover, Asia Pacific has huge growth potential, driven by a rapidly aging population, forming a huge potential consumer base for anti-aging therapeutics.
This report provides an in-depth look at the anti-aging therapeutics market, analysing its key drivers, challenges and future prospects. It also delves into the evolving landscape of anti-aging treatments and their potential to redefine health in an aging society.
Some of the major market players operating in the anti-aging therapeutics market include AgelessRx, ANOVA Institute for Regenerative Medicine, Betterhumans, BioAge Labs, BIOPHYTIS BSA, bioXcellerator, Cambrian Biopharma, CytoMed Therapeutics, Gero.ai, Rejuvenate Bio, Rejenevie Therapeutics, UT Health San Antonio, MyMD Pharmaceuticals, Intervene Immune, Inc., CohBar, Inc., Alkahest, Athersys Inc, and BHB Therapeutics.
Biosplice, Cyclo Therapeutics, Denali Therapeutics, Elysium Health, Genome Protection, GenSight Biologics, Intervene Immune, Khondrian, Longeveron, LyGenesis, Mesoblast, Minovia Therapeutics, Mitobridge, Navitor Pharmaceuticals, NeuroTrack, Nuchido, NuSirt, OneSkin Technologies, PharmatrophiX, Proteostasis Therapeutics, Retrotope, Stealth Biotherapeutics, TA Sciences, Unity BiotechnologyYounger Phenotype, and other prominent companies.
Recent collaborations and agreements in the market:
• In February 2022, Cambrian Biopharma announced that it had entered into a licensing agreement with Novartis to advance new select medicines targeting the mTOR pathway. Novartis conceived and defined these substances. According to a statement from Cambrian Biopharma, the licensed assets are structural analogs of the drug rapamycin. According to data provided by Cambrian Biopharma, the drug has been demonstrated to extend the lifespan of mice by up to 31% and prevent or reverse several age-related health disorders.
• In May 2019, RejenevieTM Therapeutics initiated a Phase II clinical trial to investigate the safety and efficacy of its novel AR-100 immune restoration therapy aimed at improving immune system function as the body ages. The biotechnology company is in the clinical stage of development and has developed the first stem cell therapy to treat age-related diseases.
Interested in this latest edition of the report? Get more details on the report here https://www.insightaceanalytic.com/enquiry-before-buying/1249
Market Segments
Global Anti-Aging Therapeutics Market, by Molecule Type, 2022-2030 (Value USD Million)
• Biological agents
• Small molecules
Global Anti-Aging Therapeutics Market by Aging Type, 2022-2030 (Value USD Million)
• Cellular aging
• Immune aging
• Metabolic aging
• others
Global Anti-Aging Therapeutics Market by Mechanism of Action, 2022-2030 (Value USD Million)
• Senolytic
• Cell regeneration
• mTOR inhibitors/modulators
• AMP kinase/AMP activator
• Mitochondrial inhibitors/modulators
• others
Global Anti-Aging Therapeutics Market, by Region, 2022-2030 (Value USD Million)
• North America
• Europe
• Asia Pacific
• latin america
• Middle East and Africa
North America Anti-Aging Therapeutics Market, by Country, 2022-2030 (Value USD Million)
• we
• Canada
European Anti-Aging Therapeutics Market, by Country, 2022-2030 (Value USD Million)
• Germany
• France
• Italy
• Spain
• Russia
• Other Europe
Asia Pacific Anti-Aging Therapeutics Market, by Country, 2022-2030 (Value USD Million)
• India
• China
• Japan
• South Korea
• Australia and New Zealand
Latin America Anti-Aging Therapeutics Market, by Country, 2022-2030 (Value USD Million)
• Brazil
• Mexico
• Other Latin American countries
Middle East and Africa Anti-Aging Therapeutics Market, by Country, 2022-2030 (Value USD Million)
• GCC countries
• South Africa
o Rest of the Middle East and Africa
Reasons to buy this report:
Receive a comprehensive analysis of the global anti-aging therapeutics market outlook
To know the industry overview and future trends of the Anti-Aging Drugs Market
To analyze the drivers and challenges of the anti-aging drugs market.
Obtain information on the forecast market value (in million USD) of anti-aging drugs by 2030
Significant investments, mergers and acquisitions in the Anti-Aging Therapeutics Market industry
For more information @ https://www.insightaceanalytic.com/customisation/1249
inquiry:
InsightAce Analytics Inc.
Phone: +1 718 593 4405
Email: info@insightaceanalytic.com
Site visit: Click here for details
Follow us on LinkedIn @ bit.ly/2tBXsgS
Follow us on Facebook @ bit.ly/2H9jnDZ
About us:
InsightAce Analytic is a market research and consulting firm that helps clients make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the market and competitive intelligence you need to grow your business.
We help our clients gain competitive advantage by identifying untapped markets, exploring new competing technologies, segmenting potential markets and repositioning products.
Our expertise lies in delivering syndicated and custom market intelligence reports with in-depth analysis of key market insights in a timely and cost-effective manner.
This release was published on openPR.
